Health Care Utilization after Medical and Surgical Therapy for Gastroesophageal Reflux Disease: A Population-Based Study, 1996 to 2000

Archives of Surgery

Volumn 138, Issue 12, 2003, Pages 1356-1361

  Khaitan, Leena ^a,d   Ray, Wayne A ^b,c   Holzman, Michael D ^a   Smalley, Walter E ^a,b,c,e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISAPRIDE; FAMOTIDINE; LANSOPRAZOLE; METOCLOPRAMIDE; NIZATIDINE; OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; OUTPATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; STOMACH FUNDOPLICATION;

ADULT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DRUG UTILIZATION; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; STATISTICS, NONPARAMETRIC; TENNESSEE;

EID: 0344629894     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.12.1356     Document Type: Article

References (30)

1. Nebel OT, Fornes MT, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976;21:953-956.
2. Digestive Diseases in the United States: Epidemiology and Impact. Bethesda, Md; US Dept of Health and Human Services; 1994.
3. Slim K, Bousquet J, Kwiatkowski F, Lescure G, Pezet D, Chipponi J. Quality of life before and after laparoscopic fundoplication. Am J Surg. 2000;180:41-45.
4. McDougall NI, Johnson BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut. 1996;38:481-486.
5. Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer. JAMA. 2002;287:1972-1981.
6. Lieberman DA. Medical therapy for chronic reflux esophagitis: long-term follow-up. Arch Intern Med. 1987;147:1717-1720.
7. Behar J, Sheahan DG, Biancani P, Spiro HM, Storer EH. Medical and surgical management of reflux esophagitis: a 38-month report of a prospective clinical trial. N Engl J Med. 1975;293:263-268.
8. Behar J, Brand DL, Brown FC, et al. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology. 1978;74(2, pt 2):441-448.
9. Sontag S, Robinson M, McCallum RW, Barwick KW, Nardi R. Ranitidine therapy for gastroesophageal reflux disease: results of a large double-blind trial. Arch Intern Med. 1987;147:1485-1491.
10. Euler AR, Murdock RH Jr, Wilson TH, Silver MT, Parker SE, Powers L. Ranitidine is effective therapy for erosive esophagitis. Am J Gastroenterol. 1993;88:520-524.
11. Terry M, Smith CD, Branum GD, Galloway K, Waring JP, Hunter JG. Outcomes of laparoscopic fundoplication for gastroesophageal reflux disease and paraesophageal hernia: experience with 1000 consecutive cases. Surg Endosc. 2001;15:691-699.
12. Bowrey DJ, Peters JH. Current state, techniques, and results of laparoscopic antireflux surgery. Semin Laparosc Surg. 1999;6:194-212.
13. Hinder RA. Surgical therapy for GERD: selection of procedures, short and long-term results. J Clin Gastroenterol. 2000;30(3, suppl):S48-S50.
14. Spechler SJ, for the Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med. 1992;326:786-792.
15. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001;285:2331-2338.
16. Harary AM. Medical vs surgical treatment of gastroesophageal reflux [letter]. JAMA. 2001;286:1709.
17. DeMeester SR. Medical vs surgical treatment of gastroesophageal reflux [letter]. JAMA. 2001;286:1709.
18. Lundell L, Dalenvack J. Omeprazole or antireflux surgery in the long term management of gastroesophageal reflux disease: results of a multicentre, randomized, clinical trial. Gastroenterology. 1998;114:A207. Abstract 0848.
19. Allgood PC, Bachmann M. Medical or surgical treatment for chronic gastrooesophageal reflux? a systematic review of published evidence of effectiveness. Eur J Surg. 2000;166:713-721.
20. Fennerty MB, Castell D, Fendrick AM, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: suggested disease management guidelines. Arch Intern Med. 1996;156:477-484.
21. Heudebert GR, Marks R, Wilcox CM, Centor RM. Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology. 1997;112:1078-1086.
22. Viljakka M, Nevalainen J, Isolauri J. Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland. Scand J Gastroenterol. 1997;32:766-772.
23. Van Den Boom G, Go PM, Hameeteman W, Dallemagne B, Ament AJ. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol. 1996;31:1-9.
24. Holzman MD, Mitchel EF, Ray WA, Smalley WE. Use of healthcare resources among medically and surgically treated patients with gastroesophageal reflux disease: a population-based study. J Am Coll Surg. 2001;192:17-24.
25. Mirvis DM, Chang CF, Hall CJ, Zaar GT, Applegate WB. TennCare: health system reform for Tennessee. JAMA. 1995;274:1235-1241.
26. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129:837-849.
27. Physicians' Desk Reference. 45th ed. Montvale, NJ: Thomson Healthcare; 1991.
28. Khajanchee YS, O'Rourke RW, Lockhart B, Patterson EJ, Hansen PD, Swanstrom LL. Postoperative symptoms and failure after antireflux surgery. Arch Surg. 2002;137:1008-1014.
29. Lord RV, Kaminski A, Oberg S, et al. Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg. 2002;6:3-9.
30. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996:142-146.